EFFECTOR THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.89 USD | +4.42% |
|
+11.18% | -83.83% |
Chart calendar eFFECTOR Therapeutics, Inc.
cbd32e314b372.bFz-CZZzMjS1DnrqUrIfFIkgAd4tvX5GbIDuZ40M6t8.LTihRe4mBU3ZfU6NK_lyWc5GY7R_zAxxWrWcSuxB05kIL6962xZ3bfBUPw~5e7bc0cfd6bfc3307c19a29af61311f8
Upcoming events on eFFECTOR Therapeutics, Inc.
Past events on eFFECTOR Therapeutics, Inc.
| 16/04/2024 09:00 pm | Stifel Virtual Targeted Oncology Days Conference |
| 26/03/2024 01:31 am | Q4 2023 Earnings Release |
| 15/03/2024 07:30 pm | Investor Meeting - Stifel |
| 14/02/2024 09:10 pm | Oppenheimer Healthcare Life Sciences Conference |
| 25/01/2024 03:00 am | R&D Day |
| 08/01/2024 | Investor Meeting |
| 08/12/2023 11:30 pm | San Antonio Breast Cancer Symposium |
| 15/11/2023 11:10 pm | Stifel Healthcare Conference |
| 14/11/2023 02:44 am | Q3 2023 Earnings Release |
| 27/09/2023 12:30 am | Cantor Global Healthcare Conference |
| 13/09/2023 07:30 pm | H.C. Wainwright Global Investment Conference |
| 09/08/2023 01:31 am | Q2 2023 Earnings Release |
| 23/06/2023 01:30 am | Annual General Meeting |
| 05/06/2023 05:00 am | American Society of Clinical Oncology Conference |
| 04/06/2023 06:30 pm | American Society of Clinical Oncology Conference - Abstract No: 1080 |
| 15/05/2023 07:00 pm | JMP Securities Life Sciences Conference |
| 09/05/2023 | Q1 2023 Earnings Release |
| 25/04/2023 11:30 pm | Stifel Targeted Oncology Days |
| 03/04/2023 08:30 pm | Cantor The Future of Oncology Virtual Symposium |
| 09/03/2023 02:31 am | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 1,43 1,21 18.01% | 3,55 3,55 0.04% | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -31,9 -27,9 -14.36% | -32,4 -36,0 10.19% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -31,9 -29,9 -6.56% | -32,4 -34,2 5.25% | -33,8 -32,2 -4.96% | -30,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 15,8 -11,0 243.44% | -22,7 -23,9 5.14% | -35,8 -34,2 -4.75% | -31,9 |
|
Net income Million USD | Released Forecast Spread | 0,17 | 15,8 -11,0 243.44% | -22,7 -23,8 4.83% | -35,8 -34,2 -4.77% | -31,9 |
|
EPS USD | Released Forecast Spread | 0,25 | 11,0 -10,2 208.37% | -13,8 -14,3 3.51% | -16,4 -15,6 -4.97% | -5,18 |
| Announcement Date | 14/06/21 | 16/03/22 | 08/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,31 0,13 148.8% | 0,00 0,35 - | 2,01 0,53 283.05% | 0,87 0,64 35.05% | 0,67 0,66 1.51% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -12,4 -5,12 -142.15% | ||||||||||||
|
EBIT Million USD | Released Forecast Spread | -12,4 -9,77 -26.89% | -6,55 -11,5 42.89% | -7,88 -7,79 -1.2% | -9,25 -10,2 8.86% | -8,72 -10,5 16.98% | -9,54 -8,32 -14.66% | -7,86 -8,66 9.33% | -7,86 -7,73 -1.64% | -8,60 -7,02 -22.44% | -8,53 | -8,31 | -7,29 | -6,74 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 19,0 -9,72 295.88% | 3,07 -11,0 127.82% | -6,92 -7,61 9.08% | -9,56 -9,79 2.36% | -9,26 -9,58 3.33% | -10,0 -8,44 -18.7% | -8,36 -7,67 -9.05% | -8,30 -7,87 -5.56% | -9,13 -7,50 -21.78% | -8,90 | -8,53 | -7,51 | -6,96 |
|
Net income Million USD | Released Forecast Spread | 19,0 -9,72 295.88% | 3,07 -11,0 127.82% | -6,92 -7,61 9.08% | -9,56 -9,79 2.36% | -9,26 -9,58 3.33% | -10,0 -8,44 -18.7% | -8,36 -7,67 -9.05% | -8,30 -7,87 -5.56% | -9,13 -7,50 -21.78% | -8,90 | -8,53 | -7,51 | -6,96 |
|
EPS USD | Released Forecast Spread | 11,0 -6,00 283.33% | 1,75 -5,95 129.41% | -4,25 -4,05 -4.94% | -5,75 -5,35 -7.48% | -5,50 -5,95 7.56% | -6,00 -3,38 -77.78% | -4,25 -4,94 13.92% | -3,25 -3,08 -5.41% | -3,42 -2,73 -25.27% | -2,17 | -1,68 | -1,29 | -0,75 |
| Announcement Date | 16/03/22 | 10/05/22 | 09/08/22 | 07/11/22 | 08/03/23 | 09/05/23 | 08/08/23 | 13/11/23 | 26/03/24 | - | - | - | - |
More events
Past sector events for eFFECTOR Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EFTR Stock
- Calendar eFFECTOR Therapeutics, Inc.
